Suppr超能文献

一氧化氮合酶抑制剂诱导的僵住症。

Catalepsy induced by nitric oxide synthase inhibitors.

作者信息

Del Bel E A, da Silva C A, Guimarães F S

机构信息

Department of Physiology, School of Odontology, Campus USP, Ribeirão Preto, SP, Brazil.

出版信息

Gen Pharmacol. 1998 Feb;30(2):245-8. doi: 10.1016/s0306-3623(97)00075-x.

Abstract
  1. Previous study showed that N(G)-nitro-L-arginine (L-NOARG), an inhibitor of nitric bxide synthase, induces catalepsy in a dose-dependent manner in male albino-Swiss mice. 2. The objective of the present work was to further investigate this effect, extending it to other NOS inhibitors. 3. Results showed that L-NOARG (40-80 mg/kg i.p.), N(G)-nitro-L-arginine methylester (L-NAME, 40-160 mg/kg i.p.) or N(G)-monomethyl-L-arginine (L-NMMA, 80 mg/kg i.p.) were able to induce catalepsy in mice. The effect of L-NOARG (40 mg/kg) was antagonized by pretreatment with L-arginine (300 mg/kg), but not by D-arginine (300 mg/kg). The catalepsy-inducing effect of L-NOARG suffered rapid tolerance, showing a significant decrease after two days of chronic treatment (40 mg/kg i.p., twice a day). 4. The results suggest that interference with the formation of nitric oxide induces significant motor effects in mice.
摘要
  1. 先前的研究表明,一氧化氮合酶抑制剂N(G)-硝基-L-精氨酸(L-NOARG)可在雄性白化瑞士小鼠中以剂量依赖性方式诱发僵住症。2. 本研究的目的是进一步研究这种效应,并将其扩展到其他一氧化氮合酶抑制剂。3. 结果表明,L-NOARG(40-80毫克/千克腹腔注射)、N(G)-硝基-L-精氨酸甲酯(L-NAME,40-160毫克/千克腹腔注射)或N(G)-单甲基-L-精氨酸(L-NMMA,80毫克/千克腹腔注射)能够在小鼠中诱发僵住症。L-精氨酸(300毫克/千克)预处理可拮抗L-NOARG(40毫克/千克)的作用,但D-精氨酸(300毫克/千克)则不能。L-NOARG的僵住症诱导作用出现快速耐受,在慢性治疗两天(40毫克/千克腹腔注射,每日两次)后显著降低。4. 结果表明,干扰一氧化氮的形成会在小鼠中引起显著的运动效应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验